CN Patent

CN109516999B — 用作蛋白质激酶调节剂的化合物及其应用

Assigned to Zhejiang Taaji Hongnuo Pharmaceutical Co., Ltd. · Expires 2021-08-17 · 5y expired

What this patent protects

本发明公开了一种式Ⅰ所示的化合物，其中的各符号如权利要求中所定义。本发明的式Ⅰ所示化合物对ALK、ROS1和/或TRK激酶具有良好的抑制活性，可用于制备抑制ALK、ROS1和/或TRK激酶的药物，用于治疗癌症、疼痛、神经疾病、自身免疫疾病或发炎。

USPTO Abstract

本发明公开了一种式Ⅰ所示的化合物，其中的各符号如权利要求中所定义。本发明的式Ⅰ所示化合物对ALK、ROS1和/或TRK激酶具有良好的抑制活性，可用于制备抑制ALK、ROS1和/或TRK激酶的药物，用于治疗癌症、疼痛、神经疾病、自身免疫疾病或发炎。

Drugs covered by this patent

Patent Metadata

Patent number
CN109516999B
Jurisdiction
CN
Classification
—
Expires
2021-08-17
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Taaji Hongnuo Pharmaceutical Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.